SPBC18H10.09 Antibody

What is the SPBC18H10.09 protein and why is it studied?

SPBC18H10.09 (Uniprot: O60140) is a protein found in Schizosaccharomyces pombe (fission yeast), a model organism widely used in molecular and cellular biology research. While the specific literature on this protein is limited in the provided search results, studying yeast proteins often provides valuable insights into fundamental cellular processes that are conserved across eukaryotes. Research involving SPBC18H10.09 antibodies would typically focus on protein localization, expression levels, and interaction studies that contribute to understanding basic cellular mechanisms in S. pombe .

What applications has the SPBC18H10.09 antibody been validated for?

According to available information, the SPBC18H10.09 antibody has been specifically validated for ELISA and Western blot applications. The antibody was developed using a recombinant SPBC18H10.09 protein from S. pombe strain 972/ATCC 24843 as the immunogen, which suggests it should have high specificity for the target protein. As with all research antibodies, validation in the specific experimental context is recommended before proceeding with full-scale experiments .

What are the optimal storage conditions for SPBC18H10.09 antibody?

The SPBC18H10.09 antibody should be stored at -20°C or -80°C upon receipt. Repeated freeze-thaw cycles should be avoided as they can compromise antibody integrity and function. The antibody is supplied in liquid form with a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative. These components help maintain antibody stability during storage . Like other research antibodies, aliquoting the stock solution before freezing is recommended to minimize freeze-thaw cycles for long-term experimental planning .

What controls should I include when using SPBC18H10.09 antibody in Western blotting?

When designing Western blot experiments with SPBC18H10.09 antibody, several controls are essential:

• Positive control: Lysate from wild-type S. pombe cells expressing the SPBC18H10.09 protein

• Negative control: Lysate from a SPBC18H10.09 knockout strain (if available)

• Secondary antibody-only control: To detect non-specific binding of the secondary antibody

• Loading control: To ensure equal protein loading, typically using an antibody against a housekeeping protein such as actin or tubulin

These controls help validate antibody specificity and reliability, similar to the validation approaches described for other research antibodies in the literature .

How can I validate the specificity of SPBC18H10.09 antibody for my particular experimental context?

Validating antibody specificity is crucial for reliable research outcomes. For SPBC18H10.09 antibody, consider implementing these validation strategies:

• Genetic controls: Compare signals between wild-type cells and SPBC18H10.09 deletion strains to confirm specificity

• Tagged protein confirmation: Express SPBC18H10.09 with an epitope tag and perform dual detection with both anti-tag and anti-SPBC18H10.09 antibodies

• Blocking peptide competition: Pre-incubate the antibody with the immunizing peptide to demonstrate signal specificity

• siRNA/CRISPR knockdown: Reduce target protein expression and confirm corresponding signal reduction

• Mass spectrometry validation: Confirm the identity of immunoprecipitated proteins

These approaches follow established validation principles described in antibody research literature and should be adapted to the specific properties of the SPBC18H10.09 protein .

What are the potential cross-reactivity concerns with SPBC18H10.09 antibody?

Cross-reactivity concerns should be carefully evaluated when working with SPBC18H10.09 antibody:

• Homologous proteins: Determine if S. pombe expresses proteins with sequence similarity to SPBC18H10.09 that might cross-react

• Across species applications: If attempting to use this antibody in other yeast species or organisms, sequence alignment analysis should be performed first to evaluate potential cross-reactivity

• Post-translational modifications: Consider whether modifications might alter epitope recognition

• Non-specific binding: Particularly in immunoprecipitation experiments, non-specific binding to abundant proteins should be controlled for

Thorough validation, potentially including immunoprecipitation followed by mass spectrometry, would help identify any cross-reactivity issues .

How can I optimize the conditions for immunoprecipitation using SPBC18H10.09 antibody?

Although immunoprecipitation (IP) is not explicitly listed among the validated applications for SPBC18H10.09 antibody, researchers may consider adapting it for this purpose. Based on general antibody optimization principles:

• Antibody concentration titration: Test multiple antibody concentrations (e.g., 1-10 μg per mg of lysate)

• Buffer optimization: Evaluate different lysis and washing buffers with varying salt concentrations and detergents

• Incubation conditions: Compare different incubation temperatures and durations

• Protein A/G selection: Test both Protein A and Protein G beads as rabbit polyclonal antibodies generally work with both

• Pre-clearing: Implement lysate pre-clearing steps to reduce non-specific binding

Document each optimization step systematically and confirm successful IP through Western blotting of the precipitated material .

What approaches can be used to study protein-protein interactions involving SPBC18H10.09?

To investigate protein-protein interactions involving SPBC18H10.09, consider these methodological approaches:

• Co-immunoprecipitation (Co-IP): Pull down SPBC18H10.09 and identify interacting partners by Western blot or mass spectrometry

• Proximity labeling: Express SPBC18H10.09 fused with BioID or APEX2 to identify proximal proteins

• Yeast two-hybrid screening: Use SPBC18H10.09 as bait to screen for interacting proteins

• Fluorescence resonance energy transfer (FRET): Tag SPBC18H10.09 and potential partners with appropriate fluorophores

• Cross-linking mass spectrometry: Chemically cross-link protein complexes prior to analysis

These approaches should be validated with appropriate controls, including non-specific binding controls and confirmation with alternative methods .

What are the recommended dilutions and conditions for Western blotting with SPBC18H10.09 antibody?

Based on the available information and general principles for polyclonal antibodies, the following guidelines are recommended for Western blotting:

These recommendations should be optimized for your specific experimental conditions and sample types .

What are effective strategies for troubleshooting weak or no signal in Western blots?

When troubleshooting Western blots with SPBC18H10.09 antibody, consider these methodological approaches:

• Protein expression verification: Confirm that your samples express the target protein at detectable levels

• Sample preparation optimization:

  • Evaluate different lysis buffers

  • Include protease inhibitors to prevent degradation

  • Optimize protein concentration

• Technical adjustments:

  • Increase antibody concentration or incubation time

  • Reduce washing stringency

  • Use a more sensitive detection system

• Epitope accessibility:

  • Try different reducing conditions

  • Consider native vs. denaturing conditions

• Antibody quality check: Test the antibody with a known positive control

Systematic documentation of each variable changed will help identify the source of the problem .

How can I optimize ELISA protocols using SPBC18H10.09 antibody?

For ELISA optimization with SPBC18H10.09 antibody, the following methodological approach is recommended:

Conduct a checkerboard titration experiment to simultaneously optimize antigen and antibody concentrations for the best signal-to-noise ratio .

What approaches can be used to quantify SPBC18H10.09 protein expression levels?

For quantitative analysis of SPBC18H10.09 expression, consider these methodological approaches:

• Quantitative Western blotting:

  • Use a standard curve of recombinant protein

  • Include a loading control protein

  • Utilize digital imaging and analysis software

• ELISA-based quantification:

  • Develop a sandwich ELISA using SPBC18H10.09 antibody

  • Compare signal to a standard curve of purified protein

• Mass spectrometry:

  • Selected reaction monitoring (SRM) or parallel reaction monitoring (PRM)

  • Include isotopically labeled peptide standards

Each method has specific advantages and limitations regarding sensitivity, specificity, and throughput that should be considered based on research needs .

How can SPBC18H10.09 antibody be used to study protein localization in fission yeast?

Although immunofluorescence is not listed among the validated applications for this antibody, researchers interested in protein localization might consider these approaches:

• Immunofluorescence optimization:

  • Test different fixation methods (formaldehyde, methanol, etc.)

  • Evaluate permeabilization conditions

  • Try antigen retrieval techniques if needed

  • Test various antibody concentrations (starting around 1:100-1:500)

• Complementary approaches:

  • Express fluorescently-tagged SPBC18H10.09 (GFP, mCherry)

  • Correlate tagged protein localization with antibody staining patterns

  • Use subcellular fractionation followed by Western blotting

• Controls:

  • SPBC18H10.09 deletion strain (negative control)

  • Co-localization with known compartment markers

Careful optimization and appropriate controls are essential for reliable localization studies .

What considerations are important when studying post-translational modifications of SPBC18H10.09?

When investigating post-translational modifications (PTMs) of SPBC18H10.09, consider these methodological approaches:

• Modification-specific detection:

  • Use PTM-specific antibodies in conjunction with SPBC18H10.09 antibody

  • Consider phosphatase or other enzyme treatments as controls

• Mass spectrometry analysis:

  • Immunoprecipitate SPBC18H10.09 and analyze by MS

  • Use enrichment techniques specific to the PTM of interest

• Mobility shift analysis:

  • Analyze migration patterns in SDS-PAGE under different conditions

  • Use Phos-tag or similar technology for phosphorylation studies

• Inhibitor studies:

  • Employ specific inhibitors of modifying enzymes

  • Monitor changes in modification state

Understanding the biological context and likely modifications based on sequence analysis would help guide these investigations .

How should unexpected multiple bands in Western blots using SPBC18H10.09 antibody be interpreted?

When multiple bands appear in Western blots, systematic analysis is required:

Careful documentation of observed patterns under different experimental conditions will help determine the source of unexpected bands .

What validation standards should be applied when publishing research using SPBC18H10.09 antibody?

For publication-quality research, apply these validation standards:

• Antibody identification: Provide complete antibody information including:

  • Supplier and catalog number (CSB-PA523977XA01SXV)

  • Clone type (polyclonal)

  • Host species (rabbit)

  • Immunogen (recombinant SPBC18H10.09 protein)

• Specificity validation:

  • Genetic controls (knockout/knockdown)

  • Blocking peptide competition

  • Multiple antibody concordance

• Application-specific validation:

  • Appropriate positive and negative controls

  • Full blot images including molecular weight markers

  • Reproducibility across replicate experiments

• Data reporting:

  • Detailed methods including dilutions and incubation conditions

  • Transparent presentation of all results

  • Acknowledgment of limitations

These standards align with guidelines for antibody validation in the research community and enhance reproducibility .

What are the best practices for comparing results from different lots of SPBC18H10.09 antibody?

Lot-to-lot variation can significantly impact experimental outcomes. Consider these methodological approaches:

• Side-by-side comparison:

  • Test both lots simultaneously on identical samples

  • Document and quantify any differences in signal intensity, background, or band pattern

• Reference standard:

  • Maintain a reference sample tested with the original lot

  • Compare new lot performance against this standard

• Critical parameter evaluation:

  • Assess specificity, sensitivity, and optimal working concentration

  • Determine if protocol adjustments are needed

• Documentation:

  • Record lot numbers in laboratory notebooks and publications

  • Note any observed differences between lots

These practices help ensure experimental consistency and facilitate troubleshooting when unexpected results occur .

How can SPBC18H10.09 antibody be combined with genomic and transcriptomic data for comprehensive analysis?

Integrating antibody-based protein detection with other omics approaches provides deeper biological insights:

• Correlation analysis:

  • Compare protein levels (detected by SPBC18H10.09 antibody) with mRNA expression

  • Identify post-transcriptional regulation mechanisms

• Genetic perturbation studies:

  • Use CRISPR or RNAi to modify gene expression

  • Monitor corresponding protein level changes via Western blot

• Multi-omics experimental design:

  • Collect samples for parallel genomic, transcriptomic, and proteomic analysis

  • Implement consistent sample preparation and data normalization

• Data integration frameworks:

  • Apply computational methods to integrate protein data with other omics datasets

  • Identify regulatory networks and functional relationships

This integrated approach provides a more comprehensive understanding of biological processes involving SPBC18H10.09 .

What considerations are important when planning long-term studies using SPBC18H10.09 antibody?

For long-term research projects, strategic planning ensures consistent results:

• Antibody supply management:

  • Purchase sufficient quantity for the entire project when possible

  • Aliquot and store according to manufacturer recommendations

  • Document lot numbers and performance characteristics

• Validation standards:

  • Establish baseline performance metrics

  • Create reference samples for regular quality checks

  • Maintain detailed protocols for all applications

• Alternative detection strategies:

  • Develop complementary approaches (e.g., tagged protein expression)

  • Identify alternative antibodies targeting different epitopes

• Data management plan:

  • Implement consistent analysis workflows

  • Establish clear metadata documentation standards

  • Plan for potential protocol adjustments

These considerations help mitigate risks associated with reagent variability in extended studies .